Trial Profile

A Sequential Treatment Regimen of Cryotherapy and Picato for the Treatment of Actinic Keratosis on the Face and Scalp.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 12 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ingenol mebutate (Primary)
Indications Actinic keratosis; Skin cancer
Focus Therapeutic Use
Acronyms FIELD Study 1

Most Recent Events

21 Oct 2013 11 week results are expected to be published by the end of 2013, according to a LEO Pharma media release.
21 Oct 2013 Primary endpoint 'Objective-clinical-response-rate' has been met.
21 Oct 2013 Primary endpoint 'Complete-clinical-response-rate' has been met.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com